A genetic tool to introduce marker-free deletions is essential for multiple manipulations of genomes. We report a simple and efficient method to create marker-free deletion mutants of Bacillus subtilis through transformation with recombinant PCR products, using the Escherichia coli mazF gene encoding an endoribonuclease that cleaves free mRNAs as a counter-selection tool. Our method will be applicable to any bacterium in which introduction of the mazF cassette into the genome by double crossover homologous recombination is possible.
Antibiotic-resistance or other selectable marker genes are routinely used to create new strains of bacteria in which a particular genomic region is replaced and inactivated by a DNA fragment containing the marker gene (termed a marker cassette). However, the insertion of a constitutively expressed marker gene often alters the expression of adjacent genes, affecting phenotypes resulting from the inactivation of functions encoded in the deleted sequence. To overcome this problem, elimination of the marker cassette in the primary transformant, through intra-molecular homologous recombination at FRT sites (FLP recognition targets) placed at both ends of the cassette, using a helper plasmid encoding the FLP recombinase (Datsenko and Wanner, 2000) , has been widely used in work with Escherichia coli. Furthermore, the use of a genetic tool to introduce marker-free deletions is essential for multiple manipulations of genomes. Cleavage at 18-bp I-SceI recognition sites at both ends of a marker cassette, by a plasmid-encoded I-SceI meganuclease, followed by isolation of viable cells in which the gap in genomic DNA generated by the I-SceI digestion is sealed by RecA-mediated double-strand repair, has been used to create E. coli strains with genomic reductions of up to 15% (Kolisnychenko et al., 2002; Posfai et al., 2006) . However, these methods require the introduction of helper plasmids that express FLP recombinase or I-SceI nuclease, and the curing of such plasmids after removal of the cassettes. In addition, FRT or I-SceI recognition sequences remain at deleted sites. To introduce multiple deletions in the absence of any residual exogenous nonnative sequences, Hashimoto et al. (2005) used the Bacillus subtilis levansucrase (sacB) gene (that makes E. coli sensitive to sucrose) as a counterselection tool for positive selection of sacB loss by cultivating cells in the presence of a high concentration of sucrose.
A number of counterselection systems, the loss of which can be positively selected, have also been developed to manipulate the B. subtilis genome. We reduced the B. subtilis genome by step-by-step deletion, using the upp (encoding uracil-phosphoribosyltransferase) cassette and 5-fluorouracil (5-FU) selection (Fabret et al., 2002) , to select cells that had lost a drug-resistant cassette used to introduce primary deletions through intra-molecular homologous recombination at repeated sequences flanking the cassette (Morimoto et al., 2008) . We also developed a system using the AraR repressor to improve the efficiency at which marker-free mutants can be obtained . In this method, we replaced the native araR gene with a promoter-less neomycin-resistance gene (neo) fused to the arabinose operon (ara) promoter and the selection marker cassette containing a chloramphenicol-resistance gene and the araR gene encoding the repressor for the ara operon was then integrated into the target site. Transformants became neomycin-sensitive after integration of the marker cassette due to the repression of neo expression by AraR, and marker cassette-free cells were obtained by selection for neomycin resistance. However, the methods described above require use of specific genetic backgrounds, such as inactivation of the The mazF gene encodes the toxin of the E. coli toxinantitoxin (TA) system mazEF; the toxin is an endoribonuclease that specifically cleaves free mRNAs at ACA sequences. MazF expression in B. subtilis is also highly toxic. Creation of marker-free deletions of B. subtilis genomic sequences using the method of Zhang et al. (2006) is schematically shown in Fig. 1a . Upstream and downstream sequences (fragments A and B) of the region to be deleted are cloned into multiple cloning sites flanking the mazF cassette on a plasmid. The mazF cassette contains mazF under the control of an IPTG-inducible spac promoter (Pspac), a lacI gene controlling the spac promoter, and a spectinomycin-resistance gene (spec R ).
The cassette also contains 125-bp direct repeat (DR) sequences at either end. A double-crossover event between the linearized delivery plasmid and the genome integrates the mazF cassette into the target locus. Next, a single-crossover event between the two DR sequences leads to excision of the mazF cassette, generating an IPTG-resistant strain. We aimed to construct clean deletion mutants without any additional sequence in a simpler manner, avoiding cloning of the B. subtilis genomic fragments in E. coli by fusing the MazF-encoding cassette with flanking sequences of the target region using recombinant PCR. However, crossover at DR sequences flanking the MazF-encoding cassette interfered with amplification of the desired PCR product. Thus, we designed sequences for double-crossover to integrate the MazF-encoding cassette, and a sequence for singlecrossover to excise it, as shown in Fig. 1b . We now routinely use the new method to obtain marker-free deletion mutants, and several examples of deletions ranging from 8.5-128 kbp are shown in Fig.  2 . We amplified about 500 bp of DNA sequences flanking each region to be deleted (fragments A and B) from the genomic DNA of wild-type cells. DNA fragments thus obtained were purified using Wizard SV Gels and a PCR clean-up kit (Promega, Madison, WI). About 0.1 μg of each DNA was used as template in a 100 μL recombinant PCR reaction. Separately, we amplified an internal sequence (fragment C) in the target region. We usually amplified about 500 bp located 4-5 kbp from the end of fragment A or B. However shorter sequence (300 bp) located more adjacent to fragment A and B could be used as inner fragment to obtain small deletions. The MazFencoding cassette was obtained by PCR from the genomic DNA of the newly created strains TMO310 or TMO311 (Fig. 3) . Three PCR products, fragment A-B, the MazFencoding cassette, and fragment C, were purified as described above, and fused by a second step of recombinant PCR. Next, 10 μg of purified final PCR product was used to transform wild-type B. subtilis competent cells, prepared by a standard protocol (Anagnostopoulos and Spizizen, 1961) . Transformants were selected on LB agar plates containing 100 μg/mL spectinomycin or 5 μg/ mL kanamycin, followed by evaluation of IPTG-sensitive growth. Next, transformants were cultivated overnight in LB liquid medium, and spread on LB agar plates containing 1 mM IPTG, after appropriate dilution, to Fig. 3 . Construction of B. subtilis strains harboring the mazF cassette in the aprE locus. DNA sequence from the initiation to the termination codon of mazF was amplified by PCR from E. coli W3110 genomic DNA. DNA from the lacI gene to the SD sequence downstream of Pspac was PCR-amplified from the B. subtilis expression vector pO2HC (Ishikawa et al., 2006) . The two amplified DNA fragments were fused by recombinant PCR using 20 bp overlapping sequences introduced in appropriate primers, followed by ApaI and BamHI digestion (the recognition sequences were also introduced with primers), and ligated, by DNA ligase, with ApaI-and BamHI-digested pAPNC213 (Morimoto et al., 2002) or pAPNCK (Yoshimura et al., 2007) . As we could not obtain E. coli transformants using the ligation mixture, probably because of leakiness of the lacI-Pspac system in E. coli, the ligation mixture was employed to directly transform B. subtilis 168 cells, with selection for spectinomycin-or kanamycin-resistance, to obtain strains TMO310 (168, aprE::spec R , lacI, Pspac-mazF) and TMO311 (168, aprE::Km R , lacI, Pspac-mazF), respectively. These strains do not grow on LB agar plates containing 100 μM IPTG. Genes in parenthesis were used for creation of the TMO311 strain.
obtain colonies in which the MazF-encoding cassette was excised by intra-molecular homologous recombination. Spectinomycin-or kanamycin-sensitive growth confirmed cassette removal. The results included in Fig. 2 indicate that 20-60 drug-resistant transformants were routinely obtained using 10 μg recombinant PCR product, and cells that lost the integrated cassette emerged very efficiently, as PCR examination indicated that all IPTG-resistant cells were marker-free, as expected. The efficiency of excision of the MazF-encoding cassette by intra-molecular recombination is relatively constant, thus independent of the size of the DNA to be excised. This may indicate an advantage of our method in introduction of large deletions, compared with the original approach, because the efficiency of replacement of genomic sequences using the MazF-encoding cassette tends to decrease with an increase in target size.
It should be noted that expression of the mazF gene is toxic in any bacterial cell, indicating that our method will be effective in any bacterium in which introduction of the MazF cassette into the genome by double-crossover homologous recombination is possible.
Nucleotide sequences of the MazF cassette reported here have been deposited in the NCBI/EMBL/DDBJ database under accession number AB526354 and AB526355, and the TMO310 and TMO311 strains are available from us upon request.
